CMPS: COMPASS Pathways plc – Depositary Receipt (Common Stock) Stock

by  •  • Comments Off on CMPS: COMPASS Pathways plc – Depositary Receipt (Common Stock) Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 225.74
Book Value / Share 3.30
Price / Book n/a
NCAV ($M) 211.05
NCAV / Share 3.09
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.46
Return on Assets (ROA) -0.68
Return on Equity (ROE) -0.73

Liquidity (mrq)
Quick Ratio 13.33
Current Ratio 13.33

Balance Sheet (mrq) ($M)
Current Assets 261.30
Assets 275.99
Liabilities 50.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -124.04
Net Income -118.46

Cash Flow Statement (mra) ($M)
Cash From Operations -97.38
Cash from Investing -0.06
Cash from Financing 173.83

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G Integrated Core Strategies (us) Llc 5.70
02-14 13G/A Paradigm Biocapital Advisors LP 5.40
02-13 13G/A Goldsmith George Jay 7.20
01-02 13G Citadel Advisors Llc 5.00
08-28 13G TCG Crossover GP I, LLC 9.90
08-25 13G Vivo Opportunity Fund Holdings, L.P. 5.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 55,963 362,967 15.42
2024-04-18 54,521 280,807 19.42
2024-04-17 56,352 312,470 18.03
2024-04-16 119,478 142,377 83.92
2024-04-15 151,570 151,003 100.38

(click for more detail)

Similar Companies
ABCL – AbCellera Biologics Inc. ABOS – Acumen Pharmaceuticals, Inc.
ABUS – Arbutus Biopharma Corporation ACAD – ACADIA Pharmaceuticals Inc.
ACLX – Arcellx, Inc.


Financial data and stock pages provided by
Fintel.io